OHSU researchers are invited to a symposium on molecular imaging that will provide the latest research, possible projects for OHSU scientists, and a major opportunity to weigh in and discuss potential investment in these techniques at OHSU.
In Vivo Molecular Imaging symposium and discussion: A proposal for the OHSU Research Community
Friday, May 16, 1:15 to 4:30 p.m. in Vollum M1441
1:15-1:45 p.m. Refreshments, Welcome, and Description of the Proposed OHSU Facilities – Jonathan Lindner, M.D., and Fergus Coakley, M.D.
1:45-2:05 p.m. Approaches for In Vivo Molecular Imaging and Integrating Phenotype with Structure/Function – Jonathan Lindner, M.D.
2:05-2:40 p.m. Potentiation of Pre-clinical Research with Molecular Imaging – John Kurhanewicz, Ph.D.
2:40-3:15 p.m. Multimodality Imaging of Cancer Therapy – Shawn Chen, Ph.D.
3:15-3:50 p.m. PET Characterization of Molecular Biology and Therapy – Kenneth Krohn, Ph.D.
3:50-4:30 p.m. Q&A
John Kurhanewicz, Ph.D., is a professor of radiology and biomedical Imaging, and pharmaceutical chemistry at University of California, San Francisco. He has led efforts to develop new imaging biomarkers using spectroscopy and MR metabolic imaging.
Shawn Chen, Ph.D., is a senior investigator at the National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering where he is the chief for the Laboratory for Molecular Imaging and Nanomedicine.
Kenneth Krohn, Ph.D., is a professor of radiology and radiation oncology at the University of Washington where he also serves as the associate director for the Cancer Imaging Program. He has been a pioneer in the development of radionuclide probes and their integration into pre-clinical and clinical research programs.
Questions? Contact Dr. Jonathan Lindner.